Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: Studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands
Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: Studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands
复制标题
DOI:
10.1089/thy.2000.10.1023
复制
发表时间:
2000-12-01
期刊:
影响因子:
6.6
通讯作者:
Hashizume, K
中科院分区:
文献类型:
--
作者:
Hara, M;Suzuki, S;Hashizume, K
3,5,3'-Triiodo-L-thyronine (T-3) potentiates apoptosis during the all-trans-retinoic acid-induced differentiation of promyeloleukemic HL-60 cells. We examined whether the retinoid receptor-specific thyroid hormone action is present during differentiation of HL-60 cells in this study. We used two distinct retinoid receptor agonists. T-3 potentiates G(1) arrest induced by Am80, a retinoic acid receptor (RAR)-specific agonist, but had no effect on G(1) arrest induced by HX600, a retinoid x receptor (RXR)-specific agonist. Am80 alone induces the apoptosis, and T-3 enhances it. Although HX600 alone fails to increase the apoptotic fraction, T-3 enables the compounds to induce apoptosis. Am80-induced expression of CD11b, a marker for the differentiation, is enhanced by T-3 However, T-3 or HX600 or both do not affect the expression of CD11b. T-3 does not alter the amount of mRNAs of various members of the bcl-2 family. T-3, however, enhances the Am80-induced expression of bfl-1 and suppression of bcl-2. In contrast, T-3 does not alter either bfl-1 and bcl-2 expression in the presence of HX600. Our observations suggest that cooperative action of T-3 With an RXR-specific ligand is different from that with an RAR ligand in cellular apoptotic regulation and that thyroid hormone may be available as a chemotherapeutic agent in acute leukemia.